Innovative Medical Device Extends Possibility of Minimally Invasive Endovascular Repair of Aortic Aneurysms to More PatientsMINNEAPOLIS – Jan. 26, 2009 – (HSMN NewsFeed) - Medtronic, Inc. (NYSE: MDT), today reported the first enrollment in VITALITY1, the company’s post-market clinical study of its Talent Abdominal Stent Graft for the endovascular repair of abdominal aortic aneurysms.
“VITALITY will gather clinically relevant data on the safety and efficacy of the Talent Abdominal Stent Graft in a real-world U.S. patient population,” said vascular surgeon Dr. George Pliagas, who led the team at St. Mary’s Medical Center in Knoxville, Tenn., that performed the first study implant on December 29, 2008.
Full text >>
Monday, January 26, 2009
Medtronic Starts 'VITALITY,' a Post-Market Study of the Talent(TM) Abdominal Stent Graft
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment